Drug Side Effects
Search
BLADDER TRANSITIONAL CELL CARCINOMA STAGE II
BLADDER TRANSITIONAL CELL CARCINOMA STAGE II
was reported 46 times
BLADDER TRANSITIONAL CELL CARCINOMA STAGE II is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Lipid Emulsion [EPC]
1
0.0004
1
GLP-2 Analog [EPC]
1
0.0001
2
Peroxisome Proliferator Receptor alpha Agonist [EPC]
4
0.0001
3
Interleukin-17A Antagonist [EPC]
2
0.0001
4
Antimycobacterial [EPC]
1
0.0000
5
Xanthine Oxidase Inhibitor [EPC]
6
0.0000
6
Sulfonylurea [EPC]
3
0.0000
7
Nitrate Vasodilator [EPC]
2
0.0000
8
Calcium [EPC]
3
0.0000
9
Antirheumatic Agent [EPC]
2
0.0000
10
Platelet Aggregation Inhibitor [EPC]
8
0.0000
11
Integrin Receptor Antagonist [EPC]
1
0.0000
12
Folate Analog Metabolic Inhibitor [EPC]
5
0.0000
13
Angiotensin 2 Receptor Blocker [EPC]
3
0.0000
14
Tumor Necrosis Factor Blocker [EPC]
9
0.0000
15
Nonsteroidal Anti-inflammatory Drug [EPC]
9
0.0000
16
Insulin Analog [EPC]
3
0.0000
17
CD20-directed Cytolytic Antibody [EPC]
2
0.0000
18
HMG-CoA Reductase Inhibitor [EPC]
2
0.0000
19
Thiazide Diuretic [EPC]
1
0.0000
20
GLP-1 Receptor Agonist [EPC]
2
0.0000
21
Loop Diuretic [EPC]
2
0.0000
22
Alkylating Drug [EPC]
1
0.0000
23
Thalidomide Analog [EPC]
2
0.0000
24
Factor Xa Inhibitor [EPC]
1
0.0000
25
beta-Adrenergic Blocker [EPC]
1
0.0000
26
Proton Pump Inhibitor [EPC]
1
0.0000
27
Corticosteroid [EPC]
2
0.0000
28
Benzodiazepine [EPC]
1
0.0000